150 related articles for article (PubMed ID: 28541532)
21. Branched-Chain Amino Acids Exacerbate Obesity-Related Hepatic Glucose and Lipid Metabolic Disorders via Attenuating Akt2 Signaling.
Zhao H; Zhang F; Sun D; Wang X; Zhang X; Zhang J; Yan F; Huang C; Xie H; Lin C; Liu Y; Fan M; Yan W; Chen Y; Lian K; Li Y; Zhang L; Wang S; Tao L
Diabetes; 2020 Jun; 69(6):1164-1177. PubMed ID: 32184272
[TBL] [Abstract][Full Text] [Related]
22. Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.
Rabøl R; Petersen KF; Dufour S; Flannery C; Shulman GI
Proc Natl Acad Sci U S A; 2011 Aug; 108(33):13705-9. PubMed ID: 21808028
[TBL] [Abstract][Full Text] [Related]
23. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.
Alves-Bezerra M; Li Y; Acuña M; Ivanova AA; Corey KE; Ortlund EA; Cohen DE
Hepatology; 2019 Aug; 70(2):496-510. PubMed ID: 30516845
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
25. Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvement.
Ono H; Shimano H; Katagiri H; Yahagi N; Sakoda H; Onishi Y; Anai M; Ogihara T; Fujishiro M; Viana AY; Fukushima Y; Abe M; Shojima N; Kikuchi M; Yamada N; Oka Y; Asano T
Diabetes; 2003 Dec; 52(12):2905-13. PubMed ID: 14633850
[TBL] [Abstract][Full Text] [Related]
26. Glucose transporter 8 (GLUT8) mediates fructose-induced de novo lipogenesis and macrosteatosis.
DeBosch BJ; Chen Z; Saben JL; Finck BN; Moley KH
J Biol Chem; 2014 Apr; 289(16):10989-10998. PubMed ID: 24519932
[TBL] [Abstract][Full Text] [Related]
27. Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults.
Pramfalk C; Pavlides M; Banerjee R; McNeil CA; Neubauer S; Karpe F; Hodson L
Diabetes; 2016 Jul; 65(7):1858-67. PubMed ID: 27207513
[TBL] [Abstract][Full Text] [Related]
28. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
29. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870
[TBL] [Abstract][Full Text] [Related]
30. Free fatty acid-induced PP2A hyperactivity selectively impairs hepatic insulin action on glucose metabolism.
Galbo T; Olsen GS; Quistorff B; Nishimura E
PLoS One; 2011; 6(11):e27424. PubMed ID: 22087313
[TBL] [Abstract][Full Text] [Related]
31. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice.
Chen TC; Lee RA; Tsai SL; Kanamaluru D; Gray NE; Yiv N; Cheang RT; Tan JH; Lee JY; Fitch MD; Hellerstein MK; Wang JC
J Biol Chem; 2019 Jun; 294(23):9213-9224. PubMed ID: 31053639
[TBL] [Abstract][Full Text] [Related]
32. Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease.
Diraison F; Moulin P; Beylot M
Diabetes Metab; 2003 Nov; 29(5):478-85. PubMed ID: 14631324
[TBL] [Abstract][Full Text] [Related]
33. Interrelationships among insulin's antilipolytic and glucoregulatory effects and plasma triglycerides in nondiabetic and diabetic patients with endogenous hypertriglyceridemia.
Yki-Järvinen H; Taskinen MR
Diabetes; 1988 Sep; 37(9):1271-8. PubMed ID: 3044892
[TBL] [Abstract][Full Text] [Related]
34. Increased insulin receptor substrate 2 expression is associated with steatohepatitis and altered lipid metabolism in obese subjects.
Rametta R; Mozzi E; Dongiovanni P; Motta BM; Milano M; Roviaro G; Fargion S; Valenti L
Int J Obes (Lond); 2013 Jul; 37(7):986-92. PubMed ID: 23147115
[TBL] [Abstract][Full Text] [Related]
35. Cholic Acid Supplementation of a High-Fat Obesogenic Diet Suppresses Hepatic Triacylglycerol Accumulation in Mice via a Fibroblast Growth Factor 21-Dependent Mechanism.
Ippagunta SM; Kharitonenkov A; Adams AC; Hillgartner FB
J Nutr; 2018 Apr; 148(4):510-517. PubMed ID: 29659970
[TBL] [Abstract][Full Text] [Related]
36. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L
BMJ Open Diabetes Res Care; 2020 Mar; 8(1):. PubMed ID: 32188593
[TBL] [Abstract][Full Text] [Related]
37. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
38. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
39. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
[TBL] [Abstract][Full Text] [Related]
40. Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Soufi N; Hall AM; Chen Z; Yoshino J; Collier SL; Mathews JC; Brunt EM; Albert CJ; Graham MJ; Ford DA; Finck BN
J Biol Chem; 2014 Oct; 289(43):30177-88. PubMed ID: 25213859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
